Valpharma

Valpharma Group is a privately-held, commercial-stage pharmaceutical and nutraceutical company with a strong international footprint. It leverages over 40 years of consolidated experience across its three subsidiaries to offer a diversified portfolio of products, including solid oral dosage drugs, plant-based supplements, and cosmetics, under both its own brand and via contract manufacturing. The company emphasizes quality, innovation in formulation, and sustainability, with a business model focused on serving global health needs from development through to commercial production and distribution.

Advanced manufacturing and formulation expertise in solid oral dosage pharmaceuticals, plant-based nutraceuticals, and cosmetics. Capabilities include tech transfer, IMP batch production, and handling of psychotropic substances.

Valpharma competes with large multinational CDMOs and generic drug manufacturers (e.g., Viatris, Teva) as well as specialized nutraceutical and cosmetic contract manufacturers. Its differentiation lies in its integrated offering across pharma and wellness, its plant-based expertise, and its strong operational base in a regulatory-friendly jurisdiction like San Marino.